The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Share News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Shares Cancelled Or Suspended In London Over Delayed Results

Thu, 02nd Jan 2020 09:36

(Alliance News) - Shares in Amphion Innovations PLC were cancelled from trading in London on Thursday due to delayed publication of its 2018 results, while another five companies' shares were suspended for the same reason.

Amphion's shares have been cancelled from trading on AIM as it has still not published its 2018 annual results. Amphion was a medical, life science, and technology business developer but became a cash shell in November 2019 when it sold its stake in Polarean Imaging PLC for USD2.6 million. Trading in its shares was suspended in June 2019.

Real estate investment trust KCR Residential REIT PLC, mobile content distributor Mobile Streams PLC, oil & gas explorer Pantheon Resources PLC, and gaming technology platform Nektan PLC all have had trading in their AIM shares suspended on Thursday pending publication of their audited annual results.

In addition, Carclo PLC has requested the suspension of its share listing on the London Main Market - having failed to publish its interim results. This follows delays to the publication of its annual results for its financial year ended March 2019 and work needed to exit its loss-making Wipac Ltd business.

Plastic parts manufacturer Carclo said it is at an advanced stage in the preparation of its interim results and these will be published "as soon as possible".

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
13 Jul 2016 14:12

Amphion draws down on loan, notes possible Motif Bio IPO

(ShareCast News) - Medical, life science and technology business developer Amphion Innovations announced on Wednesday that it has agreed terms for the drawdown of an additional tranche of $0.75m under the loan facility first announced on 5 June 2014. The AIM-traded company said it will receive the p

Read more
13 Jul 2016 09:43

WINNERS & LOSERS SUMMARY: Poundland Jumps On Steinhoff Takeover Deal

Read more
13 Jul 2016 08:13

Motif Bio Shares Rise As It Files To List On NASDAQ Market (ALLIPO)

Read more
23 Jun 2016 13:27

Amphion increases NAV through Motif Bio investment

(ShareCast News) - Medical and technology business developer Amphion Innovations announced its audited results for the 2015 calendar year on Thursday, in which it increased its net asset value per ordinary share in the company by 0.7p to 3.8p. The AIM-traded firm raised £2.1m during the period, thro

Read more
23 Jun 2016 09:01

Amphion Reports Huge Net Asset Value Rise Thanks To Motif Bio

Read more
29 Apr 2016 15:08

Amphion Innovations Agrees Additional Drawdown Of Loan (ALLISS)

Read more
28 Apr 2016 09:01

Amphion Innovations To Draw Debt To Repay Existing Borrowings

Read more
7 Apr 2016 08:49

Amphion Agrees USD1.6 Million Settlement Of Berkeley Research Dispute

Read more
5 Jan 2016 11:06

Amphion Innovations buys itself time over promissory notes

(ShareCast News) - Amphion Innovations worked to assure investors on Tuesday it had bought itself some time over its promissory notes. The AIM-listed developer of medical and technology businesses reported on a meeting of the holders of the company's unsecured convertible promissory notes, which was

Read more
5 Jan 2016 08:21

Amphion Convertible Promissory Notes, Macaleer Terms Extended (ALLISS)

Read more
26 Nov 2015 09:58

Amphion Innovations To Draw Down Further Funds Under Loan Facility

Read more
5 Nov 2015 15:13

Amphion Innovations announces m2m merger

(ShareCast News) - Amphion Innovations has signed a memorandum of understanding to merge its partner company m2m Imaging Corp with an undisclosed pulmonary imaging technology. Amphion, which develops medical, life science and technology businesses, said it expects to own around 40% of the combined m

Read more
5 Nov 2015 10:57

Amphion Innovations Proposes Merging m2m With Imaging Company

Read more
30 Oct 2015 15:59

Amphion Innovations Chairman Robert James Macaleer Dies

Read more
10 Sep 2015 11:04

LONDON MARKET MIDDAY: US Shares Seen Higher With Jobs Data In Focus

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.